Über uns

Über uns

bt_bb_section_bottom_section_coverage_image

DIENSTLEISTUNGENWer wir sind

EAKIN HEALTHCARE LIMITED is a leading manufacturer of APIs used in production of Donepezil Hydrochloride and other medications used in the treatment of neurological diseases such as Alzheimer, Bell's Palsy, Parkinsons, epilepsy and seizures amongst other.
Das Unternehmen begann mit Dienstleistungen im Bereich klinischer Studien, Lieferungen und kommerzieller Verpackung. Derzeit bieten wir Verpackungs, Lagerungs und Vertriebsdienstleistungen für über 30 führende Pharmaunternehmen an.
Bringing a compound from the laboratory to the market is a long and winding road with a great number of scientific, safety and regulatory challenges. EAKIN HEALTHCARE LIMITED  has been offering high quality analytical testing and clinical research services to support drug research, patenting/registration and production.
EAKIN HEALTHCARE LIMITED works in areas such as Recombitant DNA & chemical synthesis/analysis, fermentation, chromatography and plant extraction. We specialize in supplying our clients with a range of APIs supported by integrated technical capabilities and access to complete regulatory DMF documentation, suitable for various R&D stages through commercial formulation & production.
EAKIN HEALTHCARE LIMITED Medical leverages its conveniently located network of laboratories and clinical trial facilities present in Europe, Middle East and Asia-Pacific, to deliver harmonized solutions to large pharmaceutical and biotechnology firms. Our experts provide effective and efficient testing solutions for analytical development, biologics characterization, biosafety and quality control, aswell as clinical research services. We perform a variety of tests that are bespoke, client-specific and support the full clinical development, from Phase I First-in-Human trials in our Clinical Pharmacology Units to Phase II and Phase III studies in patients.

Unsere Produkte stammen aus unseren Produktionsstätten für APIs im Nahen Osten und in Asien und sind von verschiedenen Zulassungsbehörden wie der US-FDA, EDQM, Swissmedic, PDMA, ANSM, TGA, UK-MHRA, Health Canada und anderen anerkannt.

We believe the world would be a healthier place if tomorrow’s medicines were made available today. EAKIN HEALTHCARE LIMITED is transforming the way API’s are made with a simplified, end-to-end supply chain solution for pharmaceutical and biopharmaceutical companies of all sizes.

 

 

Wir nähern uns dem Abschluss der erforderlichen behördlichen Genehmigungen und Zulassungen, einschließlich der Registrierung der Einrichtung bei der Europäischen Arzneimittel-Agentur, der Genehmigung durch das Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), der Konformitätszertifizierung gemäß der Guten Herstellungspraxis (GMP), der Großhandelserlaubnis sowie der gewerblichen Registrierung bei den deutschen Handelsbehörden. Nach Erhalt dieser Genehmigungen wird Abbey Medical Supplies Limited seinen Hauptsitz im vierten Quartal 2026 nach Deutschland verlegen.

Our global leadership is built upon a reputation for scientific and technical excellence. This includes specialized capabilities for highly potent and controlled substances, aseptic filling and lyophilization, complex formulations, solubility enhancement and difficult to manufacture APIs. There is also EAKIN HEALTHCARE LIMITED’s “OneSource™” a program that aligns development of drug substance and drug product in a coordinated drive toward proof of concept that can take months off of development timelines. As a leading global producer of API, with our unique processes, specialized medical researches, highly skilled and experienced workforce ensures that we consistently deliver unrivalled quality, cutting-edge medical solutions, reliability and regulatory compliance.
error: Content is protected !!
en_USEnglish